Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
Dawidson
I
I
Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9031.
Ar'Rajab
A
A
Lu
C
C
Melone
D
D
Provost
D
D
Wheeler
D
D
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use / Q000633:toxicity; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000175:diagnosis*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone